Stem cell manufacturing involves isolation, purification, and characterization of stem cells. Stem cells have the ability to develop into various cell types in the body during early life and growth. They are commonly used in regenerative medicine to treat degenerative diseases like Parkinson’s disease, diabetes, heart disease, etc. There is rising demand for stem cell therapies due to growing prevalence of lifestyle diseases worldwide. The global Stem Cell Manufacturing Market is estimated to be valued at US$ 12.75 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Therapeutic Applications in Regenerative Medicine
The key trend propelling the growth of the global stem cell manufacturing market is the rising application of stem cells in regenerative medicine. Stem cells have potential therapeutic applications in tissue engineering and organ regeneration due to their ability to differentiate into various cell types. Research is being conducted globally to harness the potential of stem cells to treat various life-threatening and degenerative disorders. For instance, stem cell therapy is being explored for the treatment of heart disease, diabetes, bone and cartilage damage, liver diseases, neurological disorders such as Parkinson’s disease, Alzheimer’s disease, spinal cord injuries. The rising success of clinical trials evaluating the safety and efficacy of stem cells is expected to boost the adoption of stem cell therapy, thereby driving the demand for stem cell manufacturing.
Strength: Stem cell manufacturing provides treatment options for chronic and life-threatening diseases. There is significant funding for stem cell research from both public and private sectors.
Weakness: High costs associated with stem cell therapies. Legal and ethical issues around the use of stem cells.
Opportunity: Growing geriatric population increases the demand for cell therapies. Advancements in regenerative medicine to expand applications of stem cells.
Threats: Stringent regulatory norms for approval of stem cell therapies. Emergence of alternative treatment options.
The global stem cell manufacturing market is expected to witness high growth. With advancements in technology, stem cell manufacturing has the potential to revolutionize the treatment of various diseases.
Regional analysis shows that North America currently dominates the global market due to presence of major market players and availability of funding for research activities in the region. Asia Pacific is expected to grow at the fastest rate during the forecast period supported by rising healthcare expenditure, increasing stem cell research and presence of less stringent regulatory policies in countries like China.
Key players operating in the stem cell manufacturing market are Thermo Fisher Scientific, Merck Group, Becton, Dickinson and Company, Lonza Group, Corning, and GE Healthcare. These players are focusing on capacity expansion and new product launches through collaborations with research institutes to strengthen their market position. For example, in 2022, Thermo Fisher acquired Cytiva to enhance its capabilities in cell and gene therapy manufacturing.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it